Viridian Therapeutics, Inc.

VRDN · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$99,594$102,827$155,579$42,299
Short-Term Investments$617,990$374,543$268,971$154,666
Receivables$0$102$102$451
Inventory$0$0-$6,623$0
Other Curr. Assets$20,877$9,006$6,521$2,747
Total Curr. Assets$738,461$486,478$424,550$200,163
Property Plant & Equip (Net)$3,441$3,342$2,936$2,055
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$501$604$7,605$1,491
Total NC Assets$3,942$3,946$10,541$3,546
Other Assets$0$0$0$0
Total Assets$742,403$490,424$435,091$203,709
Liabilities
Payables$2,143$2,239$14,234$2,329
Short-Term Debt$513$843$613$520
Tax Payable$0$0$0$0
Deferred Revenue$288$288$288$289
Other Curr. Liab.$44,930$23,265$18,214$10,498
Total Curr. Liab.$47,874$26,635$33,349$13,636
LT Debt$20,582$20,205$4,645$0
Deferred Rev, NC$284$573$861$1,149
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$2,024$989$1,172$1,208
Total NC Liab.$22,890$21,767$6,678$2,357
Other Liabilities$0$0$0$0
Cap. Leases$513$843$613$520
Total Liabilities$70,764$48,402$40,027$15,993
Equity
Pref Stock$188,885$206,516$142,147$133,833
Common Stock$810$540$414$239
Retained Earnings-$995,857-$725,908-$488,174-$358,300
AOCI-$10$338-$390-$157
Other Equity$1,477,811$960,536$741,067$412,101
Total Equity$671,639$442,022$395,064$187,716
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$742,403$490,424$435,091$203,709
Net Debt-$78,499-$81,779-$150,321-$41,779
Viridian Therapeutics, Inc. (VRDN) Financial Statements & Key Stats | AlphaPilot